Endocrinology/ Cardiovascular Disease

  • Cardiac transplant
  • Cardiomyopathy
  • Central precocious puberty
  • Congestive heart failure
  • Deep vein thrombosis
  • Diabetes mellitus, Type 2
  • Growth hormone deficiency
  • Hypertension
  • Obesity
  • Pulmonary arterial hypertension
  • Stroke prevention
  • Vasodilatory shock

The evidence supporting the best-care practices in endocrinology and cardiovascular disease is robust and updated frequently. Aventine has navigated the most recent evidence supporting these complex disease states and has completed dossiers and models for new products in the diabetic, hemostatic, and cardiovascular marketplaces. These projects have been very rewarding for our team as the proper management of these disease states has the potential to positively impact a vast number of managed care lives in the US and worldwide.